PSIL 006
Alternative Names: PSIL-006Latest Information Update: 30 Aug 2024
At a glance
- Originator Psilera
- Class Antidementias; Neuropsychotherapeutics
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Frontotemporal dementia